Aclaris Therapeutics (ACRS)
(Delayed Data from NSDQ)
$1.21 USD
+0.01 (0.83%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $1.22 +0.01 (0.83%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/04/2024
Time: -- |
9/2024 | $-0.09 | 30.36% |
Earnings Summary
For their last quarter, Aclaris Therapeutics (ACRS) reported earnings of -$0.15 per share, beating the Zacks Consensus Estimate of $-0.19 per share. This reflects a positive earnings surprise of 21.05%. Look out for ACRS's next earnings release expected on November 04, 2024. For the next earning release, we expect the company to report earnings of -$0.09 per share, reflecting a year-over-year increase of 78.05%.
Earnings History
Price & Consensus
Zacks News for ACRS
Is Aclaris Therapeutics (ACRS) Outperforming Other Medical Stocks This Year?
ACRS: What are Zacks experts saying now?
Zacks Private Portfolio Services